camp elisa hama antibodies hmgb1 elisa Isotype ldh assay kit mobp antibody Monoclonal Pcr pge2 elisa plc gamma 2 protein carbonyl assay protein carbonyls tbars assay kit tdgf1 triglyceride assay upp1 Vector
Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer’s disease models
- Richard
- 0
At current, therapies for Alzheimer’s illness can briefly relieve signs however can’t stop the decline of cognitive means and different neurodegenerative modifications. Dendrobium nobile Lindl alkaloid is the principle lively element of Dendrobium nobile Lindl.
Dendrobium nobile Lindl alkaloid has been proven to withstand getting old, lengthen life span, and exhibit immunomodulatory results in animals. This evaluate summarizes the mechanisms behind the neuroprotective results reported in Alzheimer’s illness animal fashions. The neuroprotective results of Dendrobium nobile Lindl alkaloid haven’t been studied in sufferers.
The mechanisms by which Dendrobium nobile Lindl alkaloid has been reported to enhance cognitive dysfunction in Alzheimer’s illness animal fashions could also be related to extracellular amyloid plaque manufacturing, regulation of tau protein hyperphosphorylation, inhibition of neuroinflammation and neuronal apoptosis, activation of autophagy, and enhanced synaptic connections.
Uncommon manifestation of ocular immune reconstitution inflammatory syndrome from mycobacterium scrofulaceum an infection in a affected person with AIDS
Immune reconstitution inflammatory syndrome (IRIS) is a standard complication following the initiation of antiretroviral remedy (ART). Essentially the most generally related pathogens embody Mycobacterium tuberculosis and Cryptococcus spp.[1] IRIS following nontuberculosis mycobacteria (NTM) an infection is rare, significantly, IRIS following NTM conjunctivitis.
Herein, we current a case of Mycobacterium scrofulaceum conjunctivitis with peripheral ulcerative keratitis and orbital cellulitis in a 45-year-old affected person with AIDS who developed IRIS 1 month after beginning ART remedy. A mixture of each systemic and topical antibiotics along with corticosteroids had been used and resulted in a passable final result with no early recurrence.
This case demonstrated a uncommon ocular IRIS manifestation involving each the exterior eye and orbit and to the creator’s data is the primary case within the literature by which M. scrofulaceum has been discovered to be concerned within the eye.
Glial TDP-43 and TDP-43 induced glial pathology, give attention to neurodegenerative proteinopathy syndromes
Since its discovery in 2006, TAR DNA binding protein 43 (TDP-43) has pushed quickly evolving analysis in neurodegenerative ailments together with amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), and limbic predominant age-related TDP-43 encephalopathy (LATE). TDP-43 mislocalization or aggregation is the hallmark of TDP-43 proteinopathy and is related to cognitive impairment that may be mapped to its regional deposition.
Research in human tissue and mannequin programs exhibit that TDP-43 might potentiate different proteinopathies such because the amyloid or tau pathology seen in Alzheimer’s Illness (AD) within the mixture of AD+LATE. Regardless of this rising physique of literature, there stay gaps in our understanding of whether or not there may be heterogeneity in TDP-43 pushed mechanisms throughout cell varieties.
The rising observations of correlation between TDP-43 proteinopathy and glial pathology recommend a relationship between the 2, together with pathogenic glial cell-autonomous dysfunction and dysregulated glial immune responses to neuronal TDP-43.
On this evaluate, we focus on the out there information on TDP-43 in glia inside the context of the neurodegenerative ailments ALS and FTLD and spotlight the present lack of understanding about glial TDP-43 interplay in AD+LATE. TDP-43 has confirmed to be a major modulator of cognitive and neuropathological outcomes. A deeper understanding of its position in numerous cell varieties might present related insights into neurodegenerative syndromes.
Affiliation of Rosacea With Cardiovascular Illness: A Retrospective Cohort Research
Background There’s rising proof that rosacea, a continual cutaneous inflammatory illness, is related to numerous systemic ailments. Nevertheless, its affiliation with heart problems (CVD) stays controversial. We aimed to analyze whether or not sufferers with rosacea are at elevated danger of growing CVD.
Strategies and Outcomes This retrospective cohort research from the Korean Nationwide Well being Insurance coverage Service-Well being Screening Cohort included sufferers with newly recognized rosacea (n=2681) and age-, sex-, and index year-matched reference populations with out rosacea (n=26 810) between 2003 and 2014. The first final result was subsequent CVD together with coronary coronary heart illness and stroke.
Multivariable Cox regression analyses had been used to judge adjusted hazard ratios for subsequent CVD adjusted for main danger elements of CVD. In contrast with the reference inhabitants (13 410 girls; imply [SD] age, 57.7 [9.2] years), sufferers with rosacea (1341 girls; imply [SD] age, 57.7 [9.2] years) displayed an elevated danger for CVD (adjusted hazard ratios, 1.20; 95% CI, 1.03-1.40) and coronary coronary heart illness (adjusted hazard ratios, 1.29; 95% CI, 1.05-1.60).
The chance for stroke was not considerably elevated (adjusted hazard ratios, 1.12; 95% CI, 0.91-1.37). Conclusions This research means that sufferers with rosacea usually tend to develop subsequent CVD. Correct training for sufferers with rosacea to handle different modifiable danger elements of CVD together with rosacea is required.
Apoptosis and its therapeutic implications in neurodegenerative ailments
Neurodegenerative issues are characterised by progressive lack of explicit populations of neurons. Apoptosis has been implicated within the pathogenesis of neurodegenerative ailments, together with Parkinson illness, Alzheimer illness, Huntington illness, and amyotrophic lateral sclerosis.
On this evaluate, we give attention to the prevailing notions related to comprehending the apoptotic demise course of, together with the morphological options, mediators and regulators of mobile apoptosis. We additionally spotlight the proof of neuronal apoptotic demise in Parkinson illness, Alzheimer illness, Huntington illness, and amyotrophic lateral sclerosis.
Moreover, we current proof of potential therapeutic brokers that might modify the apoptotic pathway within the aforementioned neurodegenerative ailments and delay illness development. Lastly, we evaluate the medical trials that had been performed to judge the usage of anti-apoptotic medication within the therapy of the aforementioned neurodegenerative ailments, in an effort to spotlight the important want for early detection and intervention of neurodegenerative ailments in people.
Adjustments in Life Expectancy of Respiratory Illnesses from Attaining Day by day PM 2.5 Normal in China: A Nationwide Observational Research
Though publicity to air air pollution will increase the danger of untimely mortality and years of life misplaced (YLL), the results of every day air high quality enchancment to the life expectancy of respiratory ailments remained unclear. We utilized a generalized additive mannequin (GAM) to evaluate the associations between every day PM2.5 publicity and YLL from respiratory ailments in 96 Chinese language cities throughout 2013-2016.
We additional estimated the avoidable YLL, potential positive factors in life expectancy, and the attributable fraction by assuming every day PM2.5 focus lower to the air high quality requirements of China and World Well being Group. Regional and nationwide outcomes had been generated by random-effects meta-analysis.
A complete of 861,494 whole respiratory ailments and 586,962 continual obstructive pulmonary illness (COPD) induced demise from 96 Chinese language cities had been recorded throughout research interval. Every 10 μg/m3 enhance of PM2.5 in 3-day transferring common (lag02) was related to 0.16 (95% CI: 0.08, 0.24) years increment in life expectancy from whole respiratory ailments.
The best impact was noticed in Southwest area with 0.42 (95% CI: 0.22, 0.62) years enhance in life expectancy. By attaining the WHO’s Air High quality Tips, we estimated that a mean of 782.09 (95% CI: 438.29, 1125.89) YLLs brought on by whole respiratory demise in every metropolis may very well be averted, which corresponded to 1.15% (95% CI: 0.67%, 1.64%) of the general YLLs, and 0.12 (95% CI: 0.07, 0.17) years increment in life expectancy.
HPS5 (NM_181507) Human Over-expression Lysate |
|||
LS011234 | BosterBio | 100ug | EUR 960 |
Description: Transient overexpression lysate of Hermansky-Pudlak syndrome 5 (HPS5), transcript variant 1 |
HPS1 (NM_000195) Human Over-expression Lysate |
|||
LS003257 | BosterBio | 100ug | EUR 960 |
Description: Transient overexpression lysate of Hermansky-Pudlak syndrome 1 (HPS1) |
HPS3 (NM_032383) Human Over-expression Lysate |
|||
LS084343 | BosterBio | 100ug | EUR 628 |
Description: Transient overexpression lysate of Hermansky-Pudlak syndrome 3 (HPS3) |
HPSE Over-expression Lysate Product |
|||
GWB-AF6AAF | GenWay Biotech | 0.1 mg | Ask for price |
HPS2 (AP3B1) (NM_003664) Human Over-expression Lysate |
|||
LS008546 | BosterBio | 100ug | EUR 628 |
Description: Transient overexpression lysate of adaptor-related protein complex 3, beta 1 subunit (AP3B1) |
HPSE2 (NM_021828) Human Over-expression Lysate |
|||
LS060495 | BosterBio | 100ug | EUR 628 |
Description: Transient overexpression lysate of heparanase 2 (HPSE2), transcript variant 1 |
Heparanase 1 (HPSE) (NM_006665) Human Over-expression Lysate |
|||
LS010855 | BosterBio | 100ug | EUR 628 |
Description: Transient overexpression lysate of heparanase (HPSE), transcript variant 1 |
Protein expression |
|||
CRO-4-Ind | Jotbody | each | Ask for price |
EP Reagent Biuret Reagent - 100ML |
|||
1011601 | Scientific Laboratory Supplies | 1L | EUR 59.4 |
RFP expression Adenovirus, in vivo ready |
|||
AVP001-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made RFP expression adenovirus, provided in PBS solution. |
CFP expression Adenovirus, in vivo ready |
|||
AVP002-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made CFP expression adenovirus, provided in PBS solution. |
GFP expression Adenovirus, in vivo ready |
|||
AVP011-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made GFP expression adenovirus, provided in PBS solution. |
YFP expression Adenovirus, in vivo ready |
|||
AVP012-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made YFP expression adenovirus, provided in PBS solution. |
BFP expression Adenovirus, in vivo ready |
|||
AVP017-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made BFP expression adenovirus, provided in PBS solution. |
Human HPS4 Protein Lysate |
|||
MBS8413154-002mg | MyBiosource | 0.02mg | EUR 365 |
Human HPS4 Protein Lysate |
|||
MBS8413154-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
YLEX Expression Kit |
|||
FYY201-1KT | Yeastern Biotech | 1 kit | Ask for price |
PEROXIDE BLOCKING REAGENT Reagent |
|||
GWB-Q00308 | GenWay Biotech | 50 ml | Ask for price |
EP Reagent Iodoplatinate Reagent - 200ML |
|||
1046300 | Scientific Laboratory Supplies | 200ML | EUR 502.2 |
EP Reagent Molybdovanadic Reagent - 100ML |
|||
1056700 | Scientific Laboratory Supplies | 100ML | EUR 59.4 |
h OCT4 expression Adenovirus, in vivo ready |
|||
AVP013-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made adenovirus express human stem cell factor, OCT4, provided in PBS solution for in vivo application. |
h SOX2 expression Adenovirus, in vivo ready |
|||
AVP014-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made adenovirus express human stem cell factor, SOX2, provided in PBS solution for in vivo application. |
293 Expression MAX-1 |
|||
EXP-711-11 | ACROBIOSYSTEMS | 1ml | EUR 214 |
Description: 293 Expression MAX-1 is expressed from - -. |
EP Reagent Methoxyphenylacetic Reagent - 100ML |
|||
1053601 | Scientific Laboratory Supplies | 100ML | EUR 490.05 |
h LIN28 expression Adenovirus, in vivo ready |
|||
AVP015-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made adenovirus express human stem cell factor, LIN28, provided in PBS solution for in vivo application. |
CNGA2 Expression vector |
|||
60642 | BPS Bioscience | 20 µg | EUR 900 |
Description: The CNGA2 expression vector is designed to express human cyclic nucleotide-gated cation channel 2 (CNGA2) in mammalian cells. |
CNGA2 Expression vector |
|||
GWB-PSFA61 | GenWay Biotech | 20ug | Ask for price |
LEXSYcon2.1 Expression Kit |
|||
EGE-1310ble | Jena Bioscience GmbH | 1Kit | EUR 1296.1 |
Description: for constitutive cytosolic or secretory protein expression |
LEXSYcon2.1 Expression Kit |
|||
EGE-1310bsd | Jena Bioscience GmbH | 1Kit | EUR 1296.1 |
Description: for constitutive cytosolic or secretory protein expression |
LEXSYcon2.1 Expression Kit |
|||
EGE-1310hyg | Jena Bioscience GmbH | 1Kit | EUR 1296.1 |
Description: for constitutive cytosolic or secretory protein expression |
LEXSYcon2.1 Expression Kit |
|||
EGE-1310neo | Jena Bioscience GmbH | 1Kit | EUR 1296.1 |
Description: for constitutive cytosolic or secretory protein expression |
LEXSYcon2.1 Expression Kit |
|||
EGE-1310pac | Jena Bioscience GmbH | 1Kit | EUR 1296.1 |
Description: for constitutive cytosolic or secretory protein expression |
LEXSYcon2.1 Expression Kit |
|||
EGE-1310sat | Jena Bioscience GmbH | 1Kit | EUR 1296.1 |
Description: for constitutive cytosolic or secretory protein expression |
pYLEX1 - Expression Vector |
|||
FYY203-5MG | Yeastern Biotech | 5mg | Ask for price |
EP Reagent Phosphomolybdotungstic Reagent - 100ML |
|||
1065000 | Scientific Laboratory Supplies | 100ML | EUR 226.8 |
Blunt E1 Expression Kit |
|||
abx098098-10rxns | Abbexa | 10 rxns | EUR 560.4 |
Blunt E2 Expression Kit |
|||
abx098873-10rxns | Abbexa | 10 rxns | EUR 560.4 |
Blunt E1 Expression Kit |
|||
abx098098-100l | Abbexa | 100 µl | EUR 712.5 |
Blunt E1 Expression Kit |
|||
abx098098-1ml | Abbexa | 1 ml | Ask for price |
Blunt E1 Expression Kit |
|||
abx098098-200l | Abbexa | 200 µl | Ask for price |
Blunt E2 Expression Kit |
|||
abx098873-100l | Abbexa | 100 µl | EUR 712.5 |
Blunt E2 Expression Kit |
|||
abx098873-1ml | Abbexa | 1 ml | Ask for price |
Blunt E2 Expression Kit |
|||
abx098873-200l | Abbexa | 200 µl | Ask for price |
RFP expression Adenovirus |
|||
AVP001 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made RFP expression adenovirus, provided in DMEM medium. |
CFP expression Adenovirus |
|||
AVP002 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made CFP expression adenovirus, provided in DMEM medium. |
GFP expression Adenovirus |
|||
AVP011 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made GFP expression adenovirus, provided in DMEM medium. |
YFP expression Adenovirus |
|||
AVP012 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made YFP expression adenovirus, provided in DMEM medium. |
BFP expression Adenovirus |
|||
AVP017 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made BFP expression adenovirus, provided in DMEM medium. |
AVIDIN/BIOTIN BLOCKING REAGENT Reagent |
|||
GWB-Q00289 | GenWay Biotech | 30 ml | Ask for price |
Gordon-McLeod Reagent (Oxidase reagent) |
|||
R026-100ML | EWC Diagnostics | 1 unit | EUR 7.76 |
Description: Gordon-McLeod Reagent (Oxidase reagent) |
LEXSinduce3 Expression Kit |
|||
EGE-1410ble | Jena Bioscience GmbH | 1Kit | EUR 3037.6 |
Description: for inducible cytosolic or secretory protein expression |
LEXSinduce3 Expression Kit |
|||
EGE-1410blecherry | Jena Bioscience GmbH | 1Kit | EUR 3037.6 |
Description: for inducible cytosolic or secretory protein expression |
LEXSinduce3 Expression Kit |
|||
EGE-1410neo | Jena Bioscience GmbH | 1Kit | EUR 3037.6 |
Description: for inducible cytosolic or secretory protein expression |
LEXSinduce4 Expression Kit |
|||
EGE-1420blecherry | Jena Bioscience GmbH | 1Kit | EUR 3037.6 |
Description: for inducible cytosolic or secretory protein expression |
Oxidase Reagent (Gordon-Macleod Reagent) |
|||
76207 | Sisco Laboratories | 100 ml | EUR 3.38 |
Description: Part B |
Rac1 Expression Vector Set |
|||
STA-454 | Cell Biolabs | 1 kit | EUR 1765.2 |
Description: Rac1 Expression Vector Set contains 3 vectors: Rac wild type, T17N dominant negative mutant, and G12V constitutively active mutant. |
RhoA Expression Vector Set |
|||
STA-456 | Cell Biolabs | 1 kit | EUR 1765.2 |
Description: RhoA Expression Vector Set contains 3 vectors: RhoA wild type, T19N dominant negative mutant, and G14V constitutively active mutant. |
NEU3 Over-expression Lysate |
|||
GWB-DL2468 | GenWay Biotech | 0.1 mg | Ask for price |
EP Reagent Sulfomolybdic Reagent R3 - 1L |
|||
1086500 | Scientific Laboratory Supplies | 1L | EUR 398.25 |
TRIpure Reagent (same as Trizol Reagent) |
|||
MBS356001-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Cdc42 Expression Vector Set |
|||
STA-455 | Cell Biolabs | 1 kit | EUR 1765.2 |
Description: Cdc42 Expression Vector Set contains 3 vectors: Cdc42 wild type, T17N dominant negative mutant, and Q61L constitutively active mutant. |
OPN expression inhibitor 1 |
|||
T62820-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: OPN expression inhibitor 1 |
OPN expression inhibitor 1 |
|||
T62820-1g | TargetMol Chemicals | 1g | Ask for price |
Description: OPN expression inhibitor 1 |
OPN expression inhibitor 1 |
|||
T62820-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: OPN expression inhibitor 1 |
OPN expression inhibitor 1 |
|||
T62820-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: OPN expression inhibitor 1 |
OPN expression inhibitor 1 |
|||
T62820-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: OPN expression inhibitor 1 |
OPN expression inhibitor 1 |
|||
HY-146064 | MedChemExpress | 10 mg | EUR 2272.76 |
Description: OPN expression inhibitor 1 (Compound 11) is an osteopontin (OPN) expression inhibitor. OPN expression inhibitor 1 can be used for breast cancer research[1]. |
pAAV-MCS Expression Vector |
|||
VPK-410 | Cell Biolabs | 10 µg | EUR 530 |
h IL6 Expression Lentivirus |
|||
LVP1144 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h CD4 Expression Lentivirus |
|||
LVP1152 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CD4, containing a RFP-Blasticidin dual selection marker. |
h IL4 Expression Lentivirus |
|||
LVP1161 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL4, containing a RFP-Blasticidin dual selection marker. |
h IL7 Expression Lentivirus |
|||
LVP1162 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL7, containing a RFP-Blasticidin dual selection marker. |
h KDR Expression Lentivirus |
|||
LVP1176 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KDR, containing a RFP-Blasticidin dual selection marker. |
h FAS Expression Lentivirus |
|||
LVP1181 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: FAS, containing a RFP-Blasticidin dual selection marker. |
h ADA Expression Lentivirus |
|||
LVP923 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ADA, containing a RFP-Blasticidin dual selection marker. |
h FAP Expression Lentivirus |
|||
LVP1307 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: FAP, containing a RFP-Blasticidin dual selection marker. |
h CD1 Expression Lentivirus |
|||
LVP1320 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: CD1, containing a RFP-Blasticidin dual selection marker. |
m FAP Expression Lentivirus |
|||
LVP1326 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for mouse target: FAP, containing a RFP-Blasticidin dual selection marker. |
h VIM Expression Lentivirus |
|||
LVP1357 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: VIM, containing a RFP-Blasticidin dual selection marker. |
h PXN Expression Lentivirus |
|||
LVP1358 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: PXN, containing a RFP-Blasticidin dual selection marker. |
m CD8 Expression Lentivirus |
|||
LVP1363 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for mouse target: CD8, containing a RFP-Blasticidin dual selection marker. |
h TPO Expression Lentivirus |
|||
LVP1371 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: TPO, containing a RFP-Blasticidin dual selection marker. |
h WAS Expression Lentivirus |
|||
LVP1429 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: WAS, containing a RFP-Blasticidin dual selection marker. |
m PGR Expression Lentivirus |
|||
LVP1455 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 346.5 |
Description: Pre-made over-expression lentivirus for mouse target: PGR containing a RFP-Blasticidin dual selection marker. |
h MAG Expression Lentivirus |
|||
LVP1485 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 346.5 |
Description: Pre-made over-expression lentivirus for human target: MAG, containing a RFP-Blasticidin dual selection marker. |
h FST Expression Lentivirus |
|||
LVP1518 | GenTarget | 1x10^8 IFU/ml x 200ul | EUR 455 |
Description: Pre-made lentivirus express human FST gene, containing a RFP-Blasticidin dual selection marker. |
pAAV-MCS Expression Vector |
|||
MBS169528-001mg | MyBiosource | 0.01mg | EUR 695 |
pAAV-MCS Expression Vector |
|||
MBS169528-5x001mg | MyBiosource | 5x0.01mg | EUR 2955 |
Total RNA Isolation Reagent (Reagent Based) |
|||
MBS402052-100mL | MyBiosource | 100mL | EUR 235 |
Total RNA Isolation Reagent (Reagent Based) |
|||
MBS402052-4Reactions | MyBiosource | 4Reactions | EUR 165 |
Human HPS4 Protein Lysate 20ug |
|||
IHUHPS4PLLY20UG | Innovative research | each | EUR 213 |
Description: Human HPS4 Protein Lysate 20ug |
FlashBAC - Baculovirus Expression System (96 reactions) |
|||
GWB-6C34E3 | GenWay Biotech | Kit | Ask for price |
FlashBAC - Baculovirus Expression System (5 reactions) |
|||
GWB-7676BB | GenWay Biotech | Kit | Ask for price |
FlashBAC - Baculovirus Expression System(24 reactions) |
|||
GWB-EB1FF8 | GenWay Biotech | Kit | Ask for price |
h OCT4 expression Adenovirus |
|||
AVP013 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made adenovirus express human stem cell factor, OCT4, provided in DMEM medium. |
h SOX2 expression Adenovirus |
|||
AVP014 | GenTarget | 1x109 IFU/ml x 50ul | EUR 418.8 |
Description: pre-made adenovirus express human stem cell factor, SOX2, provided in DMEM medium. |
h EGFR Expression Lentivirus |
|||
LVP1142 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: EGFR, containing a RFP-Blasticidin dual selection marker. |
h NRP1 Expression Lentivirus |
|||
LVP1145 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h MUC1 Expression Lentivirus |
|||
LVP1148 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h CD8a Expression Lentivirus |
|||
LVP1151 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CD8a, containing a RFP-Blasticidin dual selection marker. |
h PIGF Expression Lentivirus |
|||
LVP1154 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PIGF, containing a RFP-Blasticidin dual selection marker. |
h BRAF Expression Lentivirus |
|||
LVP1156 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: BRAF, containing a RFP-Blasticidin dual selection marker. |
h ROS1 Expression Lentivirus |
|||
LVP1158 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ROS1, containing a RFP-Blasticidin dual selection marker. |
h CD3E Expression Lentivirus |
|||
LVP1163 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL7, containing a RFP-Blasticidin dual selection marker. |
h KLK3 Expression Lentivirus |
|||
LVP1171 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KLK3, containing a RFP-Blasticidin dual selection marker. |
h NEK6 Expression Lentivirus |
|||
LVP1182 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NEK6, containing a RFP-Blasticidin dual selection marker. |
h NEK7 Expression Lentivirus |
|||
LVP1183 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NEK7, containing a RFP-Blasticidin dual selection marker. |
h CDR1 Expression Lentivirus |
|||
LVP917 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CDR1, containing a RFP-Blasticidin dual selection marker. |
h CD47 Expression Lentivirus |
|||
LVP918 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CD47, containing a RFP-Blasticidin dual selection marker. |
h ESR1 Expression Lentivirus |
|||
LVP924 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ESR1, containing a RFP-Blasticidin dual selection marker. |
r Syn1 Expression Lentivirus |
|||
LVP925 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for rat target: Syn1, containing a RFP-Blasticidin dual selection marker. |
h NME4 Expression Lentivirus |
|||
LVP932 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NME4, containing a RFP-Blasticidin dual selection marker. |
h STM2 Expression Lentivirus |
|||
LVP1210 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Pre-made over-expression lentivirus for human target: STM2, containing a RFP-Blasticidin dual selection marker. |
h CBX7 Expression Lentivirus |
|||
LVP1308 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: CBX7, containing a RFP-Blasticidin dual selection marker. |
h ACE2 Expression Lentivirus |
|||
LVP1310 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: ACE2, containing a RFP-Blasticidin dual selection marker. |
h Rab7 Expression Lentivirus |
|||
LVP1315 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: Rab7, containing a RFP-Blasticidin dual selection marker. |
h Rab5 Expression Lentivirus |
|||
LVP1316 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: Rab5, containing a RFP-Blasticidin dual selection marker. |
m ASPA Expression Lentivirus |
|||
LVP1317 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for mouse target: ASPA, containing a RFP-Blasticidin dual selection marker. |
h CD44 Expression Lentivirus |
|||
LVP1318 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: CD44, containing a RFP-Blasticidin dual selection marker. |
h MFN2 Expression Lentivirus |
|||
LVP1327 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: MFN2, containing a RFP-Blasticidin dual selection marker. |
h ANO1 Expression Lentivirus |
|||
LVP1344 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: ANO1 containing a RFP-Blasticidin dual selection marker. |
h FGL2 Expression Lentivirus |
|||
LVP1346 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: FGL2, containing a RFP-Blasticidin dual selection marker. |
h CCR2 Expression Lentivirus |
|||
LVP1354 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: CCR2, containing a RFP-Blasticidin dual selection marker. |
h NEFL Expression Lentivirus |
|||
LVP1360 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: NEFL, containing a RFP-Blasticidin dual selection marker. |
h NOS2 Expression Lentivirus |
|||
LVP1367 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: NOS2, containing a RFP-Blasticidin dual selection marker. |
h BMI1 Expression Lentivirus |
|||
LVP1372 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: BMI1, containing a RFP-Blasticidin dual selection marker. |
h PSCA Expression Lentivirus |
|||
LVP1374 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: PSCA, containing a RFP-Blasticidin dual selection marker. |
h POLQ Expression Lentivirus |
|||
LVP1421 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: POLQ containing a RFP-Blasticidin dual selection marker. |
h ARSA Expression Lentivirus |
|||
LVP1425 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: ARSA, containing a RFP-Blasticidin dual selection marker. |
h IDUA Expression Lentivirus |
|||
LVP1426 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: IDUA, containing a RFP-Blasticidin dual selection marker. |
h SGSH Expression Lentivirus |
|||
LVP1427 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: SGSH, containing a RFP-Blasticidin dual selection marker. |
h CYBB Expression Lentivirus |
|||
LVP1430 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: CYBB, containing a RFP-Blasticidin dual selection marker. |
h CAV1 Expression Lentivirus |
|||
LVP1431 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 276.5 |
Description: Over-expression lentivirus for human target: CAV1, containing a RFP-Blasticidin dual selection marker. |
m INS2 Expression Lentivirus |
|||
LVP1456 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 346.5 |
Description: Pre-made over-expression lentivirus for mouse target: INS2 containing a RFP-Blasticidin dual selection marker. |
h ROR1 Expression Lentivirus |
|||
LVP1458 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 346.5 |
Description: Pre-made over-expression lentivirus for human target: ROR1, containing a RFP-Blasticidin dual selection marker. |
h DGKA Expression Lentivirus |
|||
LVP1468 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 346.5 |
Description: Pre-made over-expression lentivirus for human target: DGKA, containing a RFP-Blasticidin dual selection marker. |
h REST_HA Expression Lentivirus |
|||
LVP1475 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 346.5 |
Description: Pre-made over-expression lentivirus for human target: REST, containing a RFP-Blasticidin dual selection marker. |
h UBR7 Expression Lentivirus |
|||
LVP1483 | GenTarget | 1x10^7 IFU/ml x 200ul | EUR 346.5 |
Description: Pre-made over-expression lentivirus for human target: UBR7, containing a RFP-Blasticidin dual selection marker. |
h MMP1 Expression Lentivirus |
|||
LVP1516 | GenTarget | 1x10^8 IFU/ml x 200ul | EUR 455 |
Description: Pre-made lentivirus express human MMP1 gene, containing a RFP-Blasticidin dual selection marker. |
h BDNF Expression Lentivirus |
|||
LVP1520 | GenTarget | 1x10^8 IFU/ml x 200ul | EUR 455 |
Description: Pre-made lentivirus express human BDNF gene, containing a RFP-Blasticidin dual selection marker. |
m CCL5 Expression Lentivirus |
|||
LVP1619 | GenTarget | 1x10^8 IFU/ml x 200ul | EUR 455 |
Description: Pre-made lentivirus express mouse CCL5 gene, containing a RFP-Blasticidin dual selection marker. |
Genomic DNA Isolation Reagent (Reagent Based) |
|||
MBS402050-100mL | MyBiosource | 100mL | EUR 255 |
Genomic DNA Isolation Reagent (Reagent Based) |
|||
MBS402050-4Reactions | MyBiosource | 4Reactions | EUR 185 |
h LIN28 expression Adenovirus |
|||
AVP015 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made adenovirus express human stem cell factor, LIN28, provided in DMEM medium. |
pscAAV-MCS Expression Vector |
|||
VPK-430 | Cell Biolabs | 10 µg | EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
h HDAC1 Expression Lentivirus |
|||
LVP1143 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h VEGFB Expression Lentivirus |
|||
LVP1146 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h PARP1 Expression Lentivirus |
|||
LVP1149 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h IL3RA Expression Lentivirus |
|||
LVP1150 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL3RA, containing a RFP-Blasticidin dual selection marker. |
h PTCH1 Expression Lentivirus |
|||
LVP1155 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PTCH1, containing a RFP-Blasticidin dual selection marker. |
h SART3 Expression Lentivirus |
|||
LVP1159 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: SART3, containing a RFP-Blasticidin dual selection marker. |
h TIGIT Expression Lentivirus |
|||
LVP1160 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: TIGIT, containing a RFP-Blasticidin dual selection marker. |
h EDNRA Expression Lentivirus |
|||
LVP1165 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: EDNRA containing a RFP-Blasticidin dual selection marker. |
h Foxp3 Expression Lentivirus |
|||
LVP1172 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: Foxp3, containing a RFP-Blasticidin dual selection marker. |
m RIKEN Expression Lentivirus |
|||
LVP1174 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for mouse target: RIKEN, containing a RFP-Blasticidin dual selection marker. |
×
The outcomes of COPD had been typically in line with whole respiratory ailments. Our findings point out that discount in every day PM2.5 concentrations would possibly result in longer life expectancy from respiratory demise.
Tags: 96 well plate cell culture anti rabbit igg anti rfp best automated cell counter biotin conjugated antibody biotinylated secondary antibody bovine serum albumin caspase 3 stain coomassie blue protein assay ctip antibody cytokine arrays cytokine elisa kit dna purification column fluorescent western blot foetal bovine serum cell culture hbss media heat inactivating fbs hsc70 antibody lactate dehydrogenase antibody lentiviral expression system mgmt antibody mirus transfection reagent nod2 antibody pcr hot start phospho h2ax prox1 antibody rna pol ii antibody strep tag antibody synaptophysin immunohistochemistry vwf antibody western blot antibody western blot scanner